Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Small Cell Lung Carcinoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Lung Neoplasms 10Burkitt Lymphoma 9Leukemia, Myeloid, Acute 8Lymphoma 7Hodgkin Disease 6Carcinoma, Non-Small-Cell Lung 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Lymphoma, B-Cell 5Sarcoma, Ewing 3Sarcoma 3Rhabdomyosarcoma 3Rhabdoid Tumor 3Retinoblastoma 3Recurrence 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neuroblastoma 3Neoplasms, Germ Cell and Embryonal 3Myelodysplastic Syndromes 3Medulloblastoma 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia 3Immunoblastic Lymphadenopathy 3Seminoma 2

Interventions

X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Magnetic Resonance Spectroscopy 5Biopsy 4ulixertinib 2tipifarnib 2selpercatinib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vincristine 2Sorafenib 2Oxaliplatin 2Irinotecan 2Gemcitabine 2Fluorouracil 2Etoposide 2Doxorubicin 2Cisplatin 2Carboplatin 2tazemetostat 1pembrolizumab 1palbociclib 1olaparib 1dostarlimab 1dehydroftorafur 1cabozantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Hepatoblastoma × Etoposide × Clear all
NCT03017326 2026-05-13

PHITT

University of Birmingham

Phase 3 Active not recruiting
450 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatoblastoma

NCT03533582 2025-12-22

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Children's Oncology Group

Phase 3 Active not recruiting
537 enrolled
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡